(Q36307379)

13 August 2017

Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation. (English)

1 reference

13 August 2017

V Bossuyt

1

1 reference

13 August 2017

O Fadare

2

1 reference

13 August 2017

M Martel

3

1 reference

13 August 2017

I T Ocal

4

1 reference

13 August 2017

B Burtness

5

1 reference

13 August 2017

F Moinfar

6

1 reference

13 August 2017

S Leibl

7

1 reference

13 August 2017

F A Tavassoli

8

1 reference

13 August 2017

1 October 2005

1 reference

International Journal of Surgical Pathology

13 August 2017

1 reference

13 August 2017

13

1 reference

13 August 2017

319-327

1 reference

13 August 2017

4

1 reference

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Primary squamous cell carcinoma (SqCC) of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Targeting the HER-kinase axis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

EGFR and EGFRvIII expression in primary breast cancer and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106689690501300403

10.1177/106689690501300403

21 January 2018

Identifiers

DOI

0 references

1 reference